Consolidated Statements of Operations (Unaudited) - USD ($)	12 Months Ended
	Feb. 28, 2017	Feb. 29, 2016
Revenue
Revenue	$ 0	$ 0
Total Revenue	0	0
OPERATING EXPENSES
General & administrative	2,338,818	3,418,235
Research & development	1,009,134	1,360,739
Total Operating Expenses	3,347,952	4,778,974
OTHER EXPENSES (INCOME)
Interest expense	1,062,389	317,238
Other income, net	(965)	(141,549)
Change in fair value of warrant liability	(2,405,985)	(349,596)
Change in fair value of put option embedded in note payable	(614,484)	10,015
Loss on sale of notes receivable	112,500	0
Loss on extinguishment of debt	1,375,829	0
Loss on settlement of accounts payable	64,323	0
Settlement expense	0	39,097
Total Other Expenses (Income)	(406,395)	(124,795)
NET LOSS	(2,941,557)	(4,654,179)
Net loss	(2,941,557)	(4,654,179)
Deemed dividend on Series B Preferred Stock issuance	(708,303)	(1,067,491)
Accrued dividends on Series B Preferred Stock	(227,163)	(267,058)
Deemed dividend to Series B Preferred stock holders for exchange of warrants	(2,340,552)	0
Loss attributable to common shareholders	$ (6,217,575)	$ (5,988,728)
Net loss per share, basic and diluted	$ (2.10)	$ (3.30)
Weighted average of shares outstanding, basic and diluted	2,965,910	1,816,060